| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Thyroid Neoplasms | 33 | 2023 | 469 | 6.100 |
Why?
|
| Environmental Exposure | 12 | 2026 | 405 | 4.620 |
Why?
|
| Air Pollution | 9 | 2026 | 119 | 3.930 |
Why?
|
| Particulate Matter | 8 | 2026 | 138 | 3.820 |
Why?
|
| Nitrates | 12 | 2013 | 35 | 2.750 |
Why?
|
| Nitrites | 11 | 2015 | 34 | 2.450 |
Why?
|
| Lymphoma, Non-Hodgkin | 14 | 2013 | 262 | 2.310 |
Why?
|
| Air Pollutants | 6 | 2025 | 116 | 2.210 |
Why?
|
| Diet | 14 | 2015 | 468 | 2.050 |
Why?
|
| Survivors | 7 | 2016 | 211 | 1.560 |
Why?
|
| Mental Health | 2 | 2025 | 219 | 1.510 |
Why?
|
| Cohort Studies | 21 | 2026 | 3202 | 1.400 |
Why?
|
| Carcinoma | 10 | 2015 | 440 | 1.370 |
Why?
|
| Middle Aged | 73 | 2026 | 29352 | 1.370 |
Why?
|
| Carcinoma, Papillary | 14 | 2023 | 165 | 1.370 |
Why?
|
| Occupational Exposure | 4 | 2017 | 99 | 1.250 |
Why?
|
| Aged | 56 | 2026 | 21701 | 1.240 |
Why?
|
| United States | 37 | 2026 | 8183 | 1.230 |
Why?
|
| Adult | 64 | 2026 | 29453 | 1.200 |
Why?
|
| Neoplasms | 9 | 2025 | 3340 | 1.090 |
Why?
|
| Water Pollutants, Chemical | 2 | 2025 | 156 | 1.080 |
Why?
|
| Female | 80 | 2026 | 51463 | 1.060 |
Why?
|
| Risk Factors | 28 | 2025 | 6224 | 1.040 |
Why?
|
| Hypertension | 2 | 2024 | 778 | 1.040 |
Why?
|
| Income | 2 | 2025 | 101 | 1.010 |
Why?
|
| Male | 69 | 2026 | 46995 | 1.010 |
Why?
|
| Humans | 105 | 2026 | 97893 | 1.000 |
Why?
|
| Cardiovascular Diseases | 2 | 2024 | 802 | 0.990 |
Why?
|
| Quality of Life | 7 | 2018 | 1891 | 0.990 |
Why?
|
| Health Status Disparities | 3 | 2025 | 234 | 0.980 |
Why?
|
| Incidence | 17 | 2025 | 1776 | 0.940 |
Why?
|
| Radon | 1 | 2025 | 8 | 0.930 |
Why?
|
| Drinking Water | 3 | 2025 | 80 | 0.930 |
Why?
|
| Mouth | 1 | 2026 | 53 | 0.920 |
Why?
|
| Population Health | 2 | 2022 | 36 | 0.900 |
Why?
|
| Anxiety | 2 | 2025 | 370 | 0.900 |
Why?
|
| Meat | 6 | 2013 | 27 | 0.900 |
Why?
|
| Social Class | 2 | 2025 | 156 | 0.890 |
Why?
|
| Adenocarcinoma, Follicular | 8 | 2016 | 60 | 0.870 |
Why?
|
| Lithium | 1 | 2025 | 61 | 0.870 |
Why?
|
| Myocardial Infarction | 2 | 2025 | 396 | 0.870 |
Why?
|
| Groundwater | 1 | 2025 | 14 | 0.870 |
Why?
|
| Occupations | 2 | 2014 | 25 | 0.840 |
Why?
|
| Blood Pressure | 3 | 2024 | 909 | 0.810 |
Why?
|
| Occupational Diseases | 2 | 2014 | 58 | 0.800 |
Why?
|
| Depression | 2 | 2025 | 616 | 0.790 |
Why?
|
| Chicago | 12 | 2026 | 1513 | 0.780 |
Why?
|
| Polymorphism, Single Nucleotide | 9 | 2016 | 2558 | 0.760 |
Why?
|
| Case-Control Studies | 20 | 2023 | 1995 | 0.730 |
Why?
|
| Insurance Coverage | 1 | 2023 | 152 | 0.710 |
Why?
|
| Sex Factors | 13 | 2015 | 1137 | 0.690 |
Why?
|
| Smoking | 7 | 2013 | 674 | 0.680 |
Why?
|
| Proportional Hazards Models | 7 | 2025 | 920 | 0.640 |
Why?
|
| Insulin | 1 | 2026 | 1224 | 0.640 |
Why?
|
| SEER Program | 13 | 2016 | 243 | 0.630 |
Why?
|
| Medicare | 1 | 2023 | 467 | 0.620 |
Why?
|
| Aged, 80 and over | 20 | 2026 | 7386 | 0.620 |
Why?
|
| Global Health | 3 | 2018 | 215 | 0.610 |
Why?
|
| Microbiota | 1 | 2026 | 467 | 0.610 |
Why?
|
| Hospitalization | 1 | 2025 | 982 | 0.600 |
Why?
|
| Stroke | 2 | 2025 | 1154 | 0.580 |
Why?
|
| Cancer Survivors | 2 | 2018 | 108 | 0.580 |
Why?
|
| Socioeconomic Factors | 5 | 2026 | 661 | 0.570 |
Why?
|
| Prevalence | 10 | 2024 | 1384 | 0.560 |
Why?
|
| Young Adult | 22 | 2026 | 7504 | 0.520 |
Why?
|
| Age Factors | 13 | 2015 | 1960 | 0.490 |
Why?
|
| Genotype | 5 | 2015 | 1888 | 0.490 |
Why?
|
| Meat Products | 3 | 2012 | 7 | 0.480 |
Why?
|
| Surveys and Questionnaires | 15 | 2025 | 3021 | 0.470 |
Why?
|
| Psychometrics | 1 | 2017 | 356 | 0.460 |
Why?
|
| Polybrominated Biphenyls | 1 | 2015 | 4 | 0.450 |
Why?
|
| Halogenated Diphenyl Ethers | 1 | 2015 | 5 | 0.450 |
Why?
|
| Resistin | 2 | 2026 | 16 | 0.440 |
Why?
|
| Ghrelin | 2 | 2026 | 31 | 0.430 |
Why?
|
| Parity | 1 | 2015 | 96 | 0.430 |
Why?
|
| Spirituality | 1 | 2015 | 111 | 0.430 |
Why?
|
| Asthma | 1 | 2023 | 1078 | 0.430 |
Why?
|
| Sezary Syndrome | 1 | 2014 | 12 | 0.430 |
Why?
|
| Environmental Pollutants | 1 | 2015 | 67 | 0.420 |
Why?
|
| Mycosis Fungoides | 1 | 2014 | 30 | 0.420 |
Why?
|
| Alcohol Drinking | 2 | 2012 | 301 | 0.410 |
Why?
|
| Graves Disease | 1 | 2014 | 36 | 0.410 |
Why?
|
| Arylamine N-Acetyltransferase | 3 | 2012 | 14 | 0.400 |
Why?
|
| National Institutes of Health (U.S.) | 2 | 2012 | 140 | 0.400 |
Why?
|
| Breast Neoplasms | 5 | 2025 | 3272 | 0.400 |
Why?
|
| Testicular Neoplasms | 4 | 2014 | 126 | 0.400 |
Why?
|
| Prospective Studies | 8 | 2025 | 4798 | 0.390 |
Why?
|
| Health Status | 1 | 2015 | 385 | 0.390 |
Why?
|
| Life Style | 1 | 2014 | 193 | 0.390 |
Why?
|
| Hypothyroidism | 2 | 2017 | 299 | 0.380 |
Why?
|
| Social Behavior | 1 | 2015 | 316 | 0.380 |
Why?
|
| Lymphoma, Mantle-Cell | 1 | 2013 | 45 | 0.370 |
Why?
|
| Adenocarcinoma, Clear Cell | 2 | 2012 | 64 | 0.360 |
Why?
|
| Water Wells | 1 | 2012 | 18 | 0.360 |
Why?
|
| Hyperthyroidism | 1 | 2012 | 77 | 0.350 |
Why?
|
| Adenocarcinoma, Mucinous | 1 | 2012 | 53 | 0.340 |
Why?
|
| Air Pollution, Indoor | 2 | 2022 | 82 | 0.330 |
Why?
|
| Connecticut | 6 | 2012 | 27 | 0.330 |
Why?
|
| Quantitative Trait Loci | 1 | 2015 | 663 | 0.320 |
Why?
|
| Diet Surveys | 4 | 2015 | 21 | 0.320 |
Why?
|
| Sexual Dysfunction, Physiological | 3 | 2012 | 76 | 0.320 |
Why?
|
| Cross-Sectional Studies | 6 | 2025 | 2037 | 0.310 |
Why?
|
| Diabetes Complications | 1 | 2011 | 176 | 0.310 |
Why?
|
| Risk | 9 | 2013 | 660 | 0.310 |
Why?
|
| Residence Characteristics | 2 | 2022 | 224 | 0.300 |
Why?
|
| Pancreatic Neoplasms | 2 | 2016 | 769 | 0.290 |
Why?
|
| Health Services Accessibility | 1 | 2014 | 532 | 0.290 |
Why?
|
| Endometrial Neoplasms | 1 | 2012 | 242 | 0.280 |
Why?
|
| Nitroso Compounds | 3 | 2013 | 12 | 0.280 |
Why?
|
| Vegetables | 3 | 2013 | 50 | 0.280 |
Why?
|
| Fruit | 3 | 2013 | 81 | 0.270 |
Why?
|
| Odds Ratio | 4 | 2014 | 724 | 0.270 |
Why?
|
| Phenotype | 1 | 2015 | 2638 | 0.270 |
Why?
|
| Biomarkers | 2 | 2026 | 2016 | 0.260 |
Why?
|
| Cytokines | 1 | 2011 | 889 | 0.260 |
Why?
|
| Smoking Cessation | 4 | 2007 | 306 | 0.250 |
Why?
|
| China | 6 | 2013 | 277 | 0.240 |
Why?
|
| Multivariate Analysis | 3 | 2015 | 1009 | 0.240 |
Why?
|
| Infertility, Male | 2 | 2011 | 29 | 0.240 |
Why?
|
| Parks, Recreational | 1 | 2026 | 10 | 0.240 |
Why?
|
| Telomere Homeostasis | 1 | 2026 | 32 | 0.230 |
Why?
|
| Chromosomes, Human | 1 | 2026 | 69 | 0.230 |
Why?
|
| Isoenzymes | 2 | 2012 | 272 | 0.230 |
Why?
|
| Pesticides | 2 | 2017 | 33 | 0.230 |
Why?
|
| Adolescent | 13 | 2021 | 10078 | 0.220 |
Why?
|
| Models, Statistical | 1 | 2009 | 600 | 0.220 |
Why?
|
| Saliva | 1 | 2026 | 134 | 0.220 |
Why?
|
| Telomere | 1 | 2026 | 130 | 0.220 |
Why?
|
| Ovarian Neoplasms | 1 | 2012 | 826 | 0.220 |
Why?
|
| Linear Models | 3 | 2015 | 424 | 0.220 |
Why?
|
| Neoplasms, Radiation-Induced | 2 | 2016 | 96 | 0.220 |
Why?
|
| Registries | 7 | 2018 | 1120 | 0.210 |
Why?
|
| Systole | 1 | 2024 | 81 | 0.210 |
Why?
|
| Diastole | 1 | 2024 | 101 | 0.210 |
Why?
|
| Longitudinal Studies | 3 | 2024 | 1283 | 0.210 |
Why?
|
| Diabetes Mellitus | 1 | 2011 | 810 | 0.210 |
Why?
|
| Vascular Stiffness | 1 | 2024 | 29 | 0.210 |
Why?
|
| Memory | 1 | 2026 | 234 | 0.200 |
Why?
|
| Troponin | 1 | 2023 | 25 | 0.200 |
Why?
|
| C-Peptide | 1 | 2023 | 191 | 0.190 |
Why?
|
| Leptin | 1 | 2023 | 101 | 0.190 |
Why?
|
| Medically Uninsured | 1 | 2023 | 72 | 0.190 |
Why?
|
| Survival Rate | 6 | 2016 | 2040 | 0.190 |
Why?
|
| Multifactorial Inheritance | 1 | 2025 | 235 | 0.190 |
Why?
|
| Logistic Models | 7 | 2024 | 1273 | 0.180 |
Why?
|
| Metabolome | 1 | 2023 | 70 | 0.180 |
Why?
|
| Interleukin-6 | 1 | 2023 | 282 | 0.180 |
Why?
|
| Racism | 1 | 2024 | 107 | 0.180 |
Why?
|
| Genetic Predisposition to Disease | 8 | 2025 | 2555 | 0.180 |
Why?
|
| Ambulatory Care | 1 | 2023 | 201 | 0.180 |
Why?
|
| Insurance, Health | 1 | 2023 | 186 | 0.180 |
Why?
|
| Feeding Behavior | 3 | 2013 | 350 | 0.180 |
Why?
|
| Bipolar Disorder | 1 | 2024 | 409 | 0.170 |
Why?
|
| Delivery of Health Care, Integrated | 1 | 2022 | 70 | 0.170 |
Why?
|
| Fetal Development | 1 | 2021 | 37 | 0.170 |
Why?
|
| Premature Birth | 1 | 2023 | 131 | 0.170 |
Why?
|
| Electronic Health Records | 2 | 2022 | 437 | 0.170 |
Why?
|
| Family Health | 2 | 2008 | 156 | 0.170 |
Why?
|
| Cooking | 1 | 2021 | 71 | 0.160 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2025 | 601 | 0.160 |
Why?
|
| Medicaid | 1 | 2023 | 276 | 0.160 |
Why?
|
| Poverty Areas | 1 | 2020 | 37 | 0.160 |
Why?
|
| Follow-Up Studies | 7 | 2016 | 4023 | 0.160 |
Why?
|
| Europe | 3 | 2014 | 356 | 0.160 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2023 | 707 | 0.160 |
Why?
|
| Infant, Newborn | 4 | 2023 | 2529 | 0.160 |
Why?
|
| Cleft Lip | 1 | 2010 | 20 | 0.150 |
Why?
|
| Cleft Palate | 1 | 2010 | 28 | 0.150 |
Why?
|
| Leiomyoma | 1 | 2024 | 225 | 0.150 |
Why?
|
| Fertility | 1 | 2010 | 120 | 0.150 |
Why?
|
| Educational Status | 2 | 2022 | 205 | 0.150 |
Why?
|
| Cytochrome P-450 Enzyme System | 1 | 2010 | 77 | 0.150 |
Why?
|
| Child | 6 | 2013 | 7680 | 0.150 |
Why?
|
| Glutathione Transferase | 1 | 2010 | 116 | 0.150 |
Why?
|
| Neoplasms, Germ Cell and Embryonal | 1 | 2010 | 63 | 0.150 |
Why?
|
| Cytochrome P-450 CYP1A1 | 1 | 2009 | 7 | 0.150 |
Why?
|
| Mental Disorders | 1 | 2024 | 484 | 0.150 |
Why?
|
| Uterine Neoplasms | 1 | 2024 | 289 | 0.150 |
Why?
|
| Practice Patterns, Physicians' | 2 | 2015 | 658 | 0.150 |
Why?
|
| Glutathione S-Transferase pi | 1 | 2009 | 18 | 0.150 |
Why?
|
| Aryl Hydrocarbon Hydroxylases | 1 | 2009 | 45 | 0.150 |
Why?
|
| Physicians | 2 | 2018 | 685 | 0.140 |
Why?
|
| Carcinoma, Transitional Cell | 1 | 2010 | 158 | 0.140 |
Why?
|
| Nitric Oxide Synthase | 1 | 2009 | 124 | 0.140 |
Why?
|
| Retrospective Studies | 5 | 2026 | 10947 | 0.140 |
Why?
|
| Primary Health Care | 1 | 2022 | 395 | 0.140 |
Why?
|
| Prognosis | 7 | 2016 | 4112 | 0.140 |
Why?
|
| Fluorosis, Dental | 1 | 2008 | 2 | 0.140 |
Why?
|
| Lymphoma, Follicular | 2 | 2014 | 73 | 0.140 |
Why?
|
| Counseling | 2 | 2007 | 191 | 0.140 |
Why?
|
| Glioma | 1 | 2010 | 309 | 0.130 |
Why?
|
| Biomedical Research | 1 | 2022 | 470 | 0.130 |
Why?
|
| Agricultural Workers' Diseases | 1 | 2017 | 19 | 0.130 |
Why?
|
| State Health Plans | 1 | 2007 | 14 | 0.130 |
Why?
|
| Genome-Wide Association Study | 2 | 2016 | 1850 | 0.130 |
Why?
|
| Social Perception | 1 | 2018 | 93 | 0.130 |
Why?
|
| Chronic Disease | 1 | 2020 | 985 | 0.130 |
Why?
|
| Alcoholic Beverages | 2 | 2012 | 12 | 0.130 |
Why?
|
| Smoking Prevention | 1 | 2007 | 47 | 0.130 |
Why?
|
| Food | 2 | 2012 | 93 | 0.130 |
Why?
|
| Biomarkers, Tumor | 3 | 2016 | 1764 | 0.130 |
Why?
|
| Bangladesh | 2 | 2015 | 361 | 0.130 |
Why?
|
| Nonprescription Drugs | 1 | 2006 | 17 | 0.120 |
Why?
|
| Early Detection of Cancer | 1 | 2022 | 550 | 0.120 |
Why?
|
| Pharmacists | 1 | 2006 | 41 | 0.120 |
Why?
|
| Patient Selection | 1 | 2020 | 720 | 0.120 |
Why?
|
| Disease-Free Survival | 3 | 2016 | 1193 | 0.120 |
Why?
|
| Urinary Bladder Neoplasms | 1 | 2010 | 401 | 0.120 |
Why?
|
| Lymphoma | 1 | 2008 | 254 | 0.120 |
Why?
|
| Collagen | 1 | 2008 | 313 | 0.120 |
Why?
|
| Cost of Illness | 2 | 2013 | 164 | 0.120 |
Why?
|
| Ultraviolet Rays | 1 | 2007 | 198 | 0.120 |
Why?
|
| Confidence Intervals | 2 | 2011 | 221 | 0.120 |
Why?
|
| DNA Methylation | 2 | 2023 | 730 | 0.120 |
Why?
|
| Students | 1 | 2007 | 196 | 0.120 |
Why?
|
| Health Promotion | 1 | 2007 | 176 | 0.110 |
Why?
|
| Rare Diseases | 1 | 2016 | 73 | 0.110 |
Why?
|
| Parathyroid Neoplasms | 1 | 2016 | 61 | 0.110 |
Why?
|
| Polymorphism, Genetic | 1 | 2009 | 831 | 0.110 |
Why?
|
| Chromatography, Gas | 1 | 2015 | 26 | 0.110 |
Why?
|
| Canada | 1 | 2015 | 210 | 0.110 |
Why?
|
| Adrenal Gland Neoplasms | 1 | 2016 | 84 | 0.110 |
Why?
|
| Epigenomics | 1 | 2016 | 111 | 0.110 |
Why?
|
| Thyrotropin | 2 | 2017 | 328 | 0.110 |
Why?
|
| Survival Analysis | 3 | 2014 | 1527 | 0.110 |
Why?
|
| Nicotine | 1 | 2006 | 218 | 0.110 |
Why?
|
| Women's Health | 2 | 2013 | 119 | 0.110 |
Why?
|
| Tobacco Use Disorder | 1 | 2006 | 130 | 0.110 |
Why?
|
| Age of Onset | 1 | 2015 | 367 | 0.110 |
Why?
|
| Thyroid Nodule | 1 | 2015 | 65 | 0.110 |
Why?
|
| Mass Spectrometry | 1 | 2015 | 190 | 0.110 |
Why?
|
| Activities of Daily Living | 1 | 2015 | 214 | 0.110 |
Why?
|
| Carcinoma, Neuroendocrine | 2 | 2013 | 46 | 0.100 |
Why?
|
| Australia | 1 | 2014 | 125 | 0.100 |
Why?
|
| Time Factors | 3 | 2011 | 5555 | 0.100 |
Why?
|
| Brain Neoplasms | 1 | 2010 | 839 | 0.100 |
Why?
|
| North America | 1 | 2014 | 210 | 0.100 |
Why?
|
| Agriculture | 1 | 2014 | 46 | 0.100 |
Why?
|
| Food Contamination | 1 | 2013 | 37 | 0.100 |
Why?
|
| Aging | 2 | 2026 | 770 | 0.100 |
Why?
|
| Health Transition | 1 | 2013 | 2 | 0.100 |
Why?
|
| Patient Outcome Assessment | 1 | 2014 | 90 | 0.100 |
Why?
|
| Adenoma | 1 | 2015 | 260 | 0.100 |
Why?
|
| Developed Countries | 1 | 2013 | 25 | 0.100 |
Why?
|
| Databases, Factual | 1 | 2018 | 1094 | 0.100 |
Why?
|
| Oryza | 1 | 2013 | 49 | 0.100 |
Why?
|
| Leukemia, Lymphocytic, Chronic, B-Cell | 1 | 2014 | 150 | 0.090 |
Why?
|
| Kaplan-Meier Estimate | 2 | 2013 | 902 | 0.090 |
Why?
|
| Diet, Western | 1 | 2013 | 45 | 0.090 |
Why?
|
| Phytanic Acid | 1 | 2012 | 3 | 0.090 |
Why?
|
| Infant | 2 | 2010 | 3329 | 0.090 |
Why?
|
| Risk Assessment | 3 | 2025 | 2580 | 0.090 |
Why?
|
| Oleic Acid | 1 | 2012 | 15 | 0.090 |
Why?
|
| Mutagens | 1 | 2012 | 29 | 0.090 |
Why?
|
| Genetic Variation | 1 | 2009 | 1445 | 0.090 |
Why?
|
| Costs and Cost Analysis | 1 | 2013 | 155 | 0.090 |
Why?
|
| Food Analysis | 1 | 2012 | 4 | 0.090 |
Why?
|
| Developing Countries | 1 | 2013 | 101 | 0.090 |
Why?
|
| Libido | 1 | 2012 | 10 | 0.090 |
Why?
|
| Quinoxalines | 1 | 2012 | 51 | 0.090 |
Why?
|
| Child, Preschool | 2 | 2010 | 4000 | 0.090 |
Why?
|
| Penile Erection | 1 | 2012 | 22 | 0.090 |
Why?
|
| Amish | 1 | 2012 | 6 | 0.090 |
Why?
|
| Pharmacies | 1 | 2012 | 12 | 0.090 |
Why?
|
| Epidemiological Monitoring | 1 | 2012 | 43 | 0.090 |
Why?
|
| Commerce | 1 | 2012 | 29 | 0.090 |
Why?
|
| Pennsylvania | 1 | 2012 | 108 | 0.090 |
Why?
|
| Dietary Fats | 1 | 2012 | 135 | 0.090 |
Why?
|
| Eating | 1 | 2012 | 164 | 0.090 |
Why?
|
| Environmental Monitoring | 1 | 2012 | 93 | 0.090 |
Why?
|
| Health Personnel | 1 | 2014 | 257 | 0.080 |
Why?
|
| Health Care Costs | 1 | 2013 | 257 | 0.080 |
Why?
|
| Hodgkin Disease | 1 | 2012 | 144 | 0.080 |
Why?
|
| Thyroid Carcinoma, Anaplastic | 1 | 2010 | 17 | 0.080 |
Why?
|
| Genomic Instability | 1 | 2011 | 90 | 0.080 |
Why?
|
| Comorbidity | 1 | 2014 | 1032 | 0.080 |
Why?
|
| Health Surveys | 1 | 2011 | 254 | 0.080 |
Why?
|
| Water Pollutants | 1 | 2010 | 2 | 0.080 |
Why?
|
| Arsenic | 1 | 2013 | 294 | 0.080 |
Why?
|
| Neoplasm Staging | 4 | 2016 | 2080 | 0.080 |
Why?
|
| Pregnancy | 3 | 2023 | 3246 | 0.080 |
Why?
|
| Pregnancy Outcome | 2 | 2023 | 278 | 0.070 |
Why?
|
| Gene Frequency | 1 | 2011 | 715 | 0.070 |
Why?
|
| Carcinoma, Medullary | 1 | 2009 | 9 | 0.070 |
Why?
|
| Sexual Behavior | 1 | 2012 | 340 | 0.070 |
Why?
|
| Clinical Competence | 1 | 2014 | 863 | 0.070 |
Why?
|
| Carcinoma, Renal Cell | 1 | 2012 | 384 | 0.070 |
Why?
|
| Sex Characteristics | 1 | 2010 | 351 | 0.070 |
Why?
|
| Diet Records | 2 | 2012 | 20 | 0.060 |
Why?
|
| Kidney Neoplasms | 1 | 2012 | 556 | 0.060 |
Why?
|
| Sex Distribution | 2 | 2008 | 176 | 0.060 |
Why?
|
| Age Distribution | 2 | 2008 | 208 | 0.060 |
Why?
|
| Models, Genetic | 1 | 2011 | 1005 | 0.060 |
Why?
|
| Water Supply | 2 | 2010 | 65 | 0.060 |
Why?
|
| Colorectal Neoplasms | 1 | 2013 | 1103 | 0.050 |
Why?
|
| Lung Neoplasms | 1 | 2007 | 2457 | 0.050 |
Why?
|
| Cell Differentiation | 1 | 2011 | 1646 | 0.050 |
Why?
|
| Biopsy, Fine-Needle | 2 | 2015 | 108 | 0.050 |
Why?
|
| Iowa | 2 | 2017 | 33 | 0.050 |
Why?
|
| Nitrogen Dioxide | 1 | 2024 | 19 | 0.050 |
Why?
|
| Cause of Death | 2 | 2013 | 278 | 0.050 |
Why?
|
| Stillbirth | 1 | 2023 | 15 | 0.050 |
Why?
|
| Infant, Low Birth Weight | 1 | 2023 | 62 | 0.050 |
Why?
|
| Family Characteristics | 1 | 2022 | 52 | 0.050 |
Why?
|
| Metabolomics | 1 | 2023 | 106 | 0.050 |
Why?
|
| Proto-Oncogene Proteins B-raf | 1 | 2023 | 169 | 0.040 |
Why?
|
| Kerosene | 1 | 2021 | 18 | 0.040 |
Why?
|
| Islam | 1 | 2022 | 35 | 0.040 |
Why?
|
| Wood | 1 | 2021 | 23 | 0.040 |
Why?
|
| Maternal-Fetal Exchange | 1 | 2021 | 77 | 0.040 |
Why?
|
| Genetic Testing | 1 | 2025 | 594 | 0.040 |
Why?
|
| Housing | 1 | 2021 | 51 | 0.040 |
Why?
|
| Fetal Growth Retardation | 1 | 2021 | 73 | 0.040 |
Why?
|
| Data Collection | 1 | 2022 | 375 | 0.040 |
Why?
|
| Maternal Exposure | 1 | 2021 | 68 | 0.040 |
Why?
|
| Nigeria | 1 | 2021 | 174 | 0.040 |
Why?
|
| Food Handling | 1 | 2010 | 8 | 0.040 |
Why?
|
| Databases as Topic | 1 | 2010 | 96 | 0.040 |
Why?
|
| Biotransformation | 1 | 2010 | 46 | 0.040 |
Why?
|
| Hemodynamics | 1 | 2024 | 745 | 0.040 |
Why?
|
| Ultrasonography, Prenatal | 1 | 2021 | 152 | 0.040 |
Why?
|
| Fetus | 1 | 2021 | 238 | 0.040 |
Why?
|
| Carcinogens | 1 | 2010 | 102 | 0.040 |
Why?
|
| Lymphoma, T-Cell | 1 | 2010 | 60 | 0.040 |
Why?
|
| Treatment Outcome | 3 | 2014 | 9682 | 0.040 |
Why?
|
| Cytochrome P-450 CYP1B1 | 1 | 2009 | 12 | 0.040 |
Why?
|
| Medical Records | 1 | 2010 | 123 | 0.040 |
Why?
|
| Neonatal Screening | 1 | 2010 | 71 | 0.040 |
Why?
|
| Asia | 1 | 2008 | 109 | 0.040 |
Why?
|
| Africa | 1 | 2008 | 112 | 0.040 |
Why?
|
| Ethanol | 1 | 2021 | 282 | 0.030 |
Why?
|
| Patient Acceptance of Health Care | 1 | 2022 | 314 | 0.030 |
Why?
|
| Population Surveillance | 1 | 2009 | 218 | 0.030 |
Why?
|
| DNA-Cytosine Methylases | 1 | 2008 | 4 | 0.030 |
Why?
|
| Procollagen | 1 | 2008 | 9 | 0.030 |
Why?
|
| Genetic Association Studies | 1 | 2010 | 310 | 0.030 |
Why?
|
| Osteocalcin | 1 | 2008 | 25 | 0.030 |
Why?
|
| Deoxyribonucleases, Type II Site-Specific | 1 | 2008 | 28 | 0.030 |
Why?
|
| Calcitonin | 1 | 2008 | 41 | 0.030 |
Why?
|
| Polymorphism, Restriction Fragment Length | 1 | 2008 | 145 | 0.030 |
Why?
|
| Data Interpretation, Statistical | 1 | 2009 | 309 | 0.030 |
Why?
|
| Collagen Type I | 1 | 2008 | 75 | 0.030 |
Why?
|
| World Health Organization | 1 | 2008 | 125 | 0.030 |
Why?
|
| North Carolina | 1 | 2017 | 58 | 0.030 |
Why?
|
| Taxes | 1 | 2007 | 6 | 0.030 |
Why?
|
| DNA | 1 | 2023 | 1274 | 0.030 |
Why?
|
| Behavior Therapy | 1 | 2007 | 100 | 0.030 |
Why?
|
| Genetic Markers | 1 | 2008 | 471 | 0.030 |
Why?
|
| Community Pharmacy Services | 1 | 2006 | 6 | 0.030 |
Why?
|
| Urban Population | 1 | 2008 | 246 | 0.030 |
Why?
|
| Dose-Response Relationship, Radiation | 1 | 2007 | 193 | 0.030 |
Why?
|
| Administration, Cutaneous | 1 | 2006 | 66 | 0.030 |
Why?
|
| Lymphoma, Large B-Cell, Diffuse | 1 | 2009 | 195 | 0.030 |
Why?
|
| Health Education | 1 | 2007 | 109 | 0.030 |
Why?
|
| California | 1 | 2006 | 169 | 0.030 |
Why?
|
| Reactive Oxygen Species | 1 | 2009 | 525 | 0.030 |
Why?
|
| Nurse's Role | 1 | 2006 | 11 | 0.030 |
Why?
|
| Substance Abuse Detection | 1 | 2006 | 14 | 0.030 |
Why?
|
| Tobacco Products | 1 | 2007 | 76 | 0.030 |
Why?
|
| Nursing Assessment | 1 | 2006 | 20 | 0.030 |
Why?
|
| Autoantibodies | 1 | 2017 | 286 | 0.030 |
Why?
|
| Oxidative Stress | 1 | 2009 | 489 | 0.030 |
Why?
|
| Alleles | 1 | 2009 | 1160 | 0.030 |
Why?
|
| Calibration | 1 | 2015 | 109 | 0.030 |
Why?
|
| Qualitative Research | 1 | 2018 | 413 | 0.030 |
Why?
|
| Thyroidectomy | 1 | 2016 | 181 | 0.030 |
Why?
|
| Triiodothyronine | 1 | 2017 | 367 | 0.030 |
Why?
|
| CpG Islands | 1 | 2016 | 177 | 0.030 |
Why?
|
| Finland | 1 | 2014 | 31 | 0.030 |
Why?
|
| Incidental Findings | 1 | 2015 | 100 | 0.030 |
Why?
|
| Tertiary Care Centers | 1 | 2015 | 130 | 0.030 |
Why?
|
| Thyroid Gland | 1 | 2016 | 297 | 0.030 |
Why?
|
| Public Health | 1 | 2006 | 161 | 0.030 |
Why?
|
| Thyroxine | 1 | 2017 | 411 | 0.030 |
Why?
|
| Patient Satisfaction | 1 | 2018 | 511 | 0.030 |
Why?
|
| Communication | 1 | 2018 | 455 | 0.030 |
Why?
|
| Health Policy | 1 | 2006 | 216 | 0.030 |
Why?
|
| Ascorbic Acid | 1 | 2013 | 41 | 0.030 |
Why?
|
| Algorithms | 1 | 2022 | 2001 | 0.030 |
Why?
|
| Spatio-Temporal Analysis | 1 | 2013 | 26 | 0.020 |
Why?
|
| Positron-Emission Tomography | 1 | 2015 | 354 | 0.020 |
Why?
|
| Iodine | 1 | 2013 | 43 | 0.020 |
Why?
|
| Adenoma, Oxyphilic | 1 | 2013 | 37 | 0.020 |
Why?
|
| Brazil | 1 | 2013 | 93 | 0.020 |
Why?
|
| Nutritional Status | 1 | 2013 | 83 | 0.020 |
Why?
|
| Factor Analysis, Statistical | 1 | 2013 | 118 | 0.020 |
Why?
|
| Physician-Patient Relations | 1 | 2018 | 580 | 0.020 |
Why?
|
| Nebraska | 1 | 2012 | 13 | 0.020 |
Why?
|
| Patient Education as Topic | 1 | 2006 | 417 | 0.020 |
Why?
|
| Ultrasonography | 1 | 2015 | 720 | 0.020 |
Why?
|
| Attitude of Health Personnel | 1 | 2018 | 684 | 0.020 |
Why?
|
| Los Angeles | 1 | 2012 | 29 | 0.020 |
Why?
|
| Critical Care | 1 | 2006 | 462 | 0.020 |
Why?
|
| Skin Diseases | 1 | 2013 | 176 | 0.020 |
Why?
|
| Sickness Impact Profile | 1 | 2011 | 29 | 0.020 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2013 | 461 | 0.020 |
Why?
|
| Mutation | 1 | 2023 | 4396 | 0.020 |
Why?
|
| Severity of Illness Index | 1 | 2006 | 2008 | 0.020 |
Why?
|
| Reproducibility of Results | 1 | 2015 | 2783 | 0.020 |
Why?
|
| Polymerase Chain Reaction | 1 | 2011 | 894 | 0.020 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2011 | 700 | 0.020 |
Why?
|
| Military Personnel | 1 | 2011 | 121 | 0.020 |
Why?
|
| Gene Expression Profiling | 1 | 2011 | 1565 | 0.010 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2015 | 2666 | 0.010 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2015 | 3606 | 0.010 |
Why?
|